N-Benzyloxycarbonyl-D-tryptophan, abbreviated CBZ-D-tryptophan or Z-D-Trp-OH, is a protected chiral amino acid used as a D-tryptophan building block in solution-phase peptide synthesis and chiral intermediate preparation. The compound is identified by CAS 2279-15-4, molecular formula C₁₉H₁₈N₂O₄, and molar mass 338.36 g mol⁻¹. Commercial model designation CBZ-D-Trp-OH is supplied as a white to off-white crystalline powder in 25 g, 100 g, 500 g, and 1 kg HDPE containers with desiccant sachets. The Cbz group blocks the α-amino position while leaving the carboxylic acid free for activation in amide bond formation. Because the carbobenzyloxy group is stable to piperidine and trifluoroacetic acid but cleaved by catalytic hydrogenolysis or hydrogen bromide in acetic acid, the product is selected when orthogonal protection of the D-tryptophan residue is required across acid and base processing steps.

How Are Chiral Purity Release Limits Set for D-Tryptophan Building Blocks?

Chiral purity is the central release criterion for CBZ-D-tryptophan in pharmaceutical peptide synthesis. The D and L enantiomers share identical molecular mass and nearly identical reversed-phase retention, so an achiral HPLC assay cannot detect enantiomeric contamination. Lot release therefore uses chiral high-performance liquid chromatography with a polysaccharide-based chiral stationary phase, typically a Chiralpak AD-H column of 250 × 4.6 mm, with a hexane/ethanol/trifluoroacetic acid mobile phase at 1.0 mL min⁻¹ and detection at 220 nm. Under those conditions, the L-enantiomer is resolved from the D-peak and is controlled to ≤0.5% area. Specific optical rotation is measured according to Ph. Eur. 2.2.7; a supplier release sheet for CBZ-D-tryptophan commonly specifies [α]²⁰_D between −18.0° and −21.0° at c=1 in methanol, while CBZ-L-tryptophan gives a positive rotation under the same conditions. Achiral assay by HPLC according to EP 2.2.29 at 220 nm is normally specified at ≥99.0% area for research-grade lots, and related-substance limits are needed because small amounts of deprotected tryptophan or benzyl side products can propagate through a coupling sequence. Residual water, ash, and organic impurities are controlled because even 0.5 wt% water can alter the effective molar charge in anhydrous coupling reactions.

Lot-specific certificates should be consulted because optical rotation can shift with residual solvent content, and chiral HPLC conditions may vary between suppliers. The absence of a chiral impurity specification is a known gap when a generic amino acid assay is applied to CBZ-D-tryptophan; achiral HPLC alone cannot distinguish the enantiomers and may produce false release of racemised material.

Removing the Carbobenzyloxy Group at Pilot Scale

De protection of CBZ-D-tryptophan is most frequently carried out by catalytic hydrogenolysis. A pilot-scale batch charge typically dissolves the protected amino acid in methanol or ethanol/water, adds 10 wt% palladium on activated carbon relative to substrate, and applies hydrogen pressure of 0.2–0.4 MPa while maintaining internal temperature below 30°C. The carbobenzyloxy fragment is cleaved to carbon dioxide and toluene, releasing D-tryptophan. Reaction monitoring by reverse-phase HPLC or thin-layer chromatography tracks disappearance of the protected substrate. Over-reduction of the indole ring is minimised by stopping hydrogen uptake immediately after substrate consumption; hydrogen pressure above 0.5 MPa or reaction times beyond 12 h should be avoided unless impurity profiling demonstrates that indole reduction is absent. An alternative non-hydrogenolytic deprotection uses 33 wt% hydrogen bromide in acetic acid at 20°C, which cleaves the Cbz group but generates benzyl bromide and requires glass-lined or fluoropolymer equipment because of corrosive vapour. Process records from kilogram-scale coupling campaigns indicate that incomplete hydrogenolysis occurs when reused catalyst activity falls below 80% of initial uptake; filtration over Celite is therefore standard after reaction and catalyst-laden filter cakes are washed to recover adsorbed product. Published kinetic data for this specific D-tryptophan configuration are limited, but the observed behaviour follows the general N-carbobenzyloxy hydrogenolysis pattern.

Refrigerated storage in tightly closed HDPE bottles at 2–8°C preserves CBZ-D-tryptophan over long campaigns. The product is hygroscopic in open air; containers opened at relative humidity above 60% should be returned to a desiccator or vacuum dried at 40°C for 4 h before gravimetric charging into anhydrous coupling reactions. A cold drum transferred into a warm production suite can condense moisture on the powder surface, and the resulting batch-to-batch variation in water content is a recognised processing bottleneck on manufacturing lines. On multi-kilogram scale, the compound is preferably charged through a nitrogen-purged glovebox when the downstream active ester or mixed anhydride formation is moisture-sensitive. Contact with strong acids such as HBr in acetic acid removes the protecting group and must be excluded during storage. The material should not be mixed with amine-based reagents once the carboxylic acid has been converted to an active ester, because premature aminolysis consumes the activated species before the intended coupling.

If a Convergent Solution-Phase Sequence Cannot Use Fmoc Deprotection, Cbz Provides a Temporary Orthogonal Mask

When a D-tryptophan residue must be incorporated by solution-phase convergent assembly rather than solid-phase Fmoc chemistry, CBZ-D-tryptophan is selected because the Cbz group remains intact during acid and base workup steps and because the free carboxylic acid permits direct activation. Coupling is performed with ethyl chloroformate and N-methylmorpholine to form a mixed anhydride, or with dicyclohexylcarbodiimide and 1-hydroxybenzotriazole at 0–5°C in anhydrous DMF. Racemisation at the D-tryptophan α-carbon is possible through oxazolone formation if the carboxylate is activated for prolonged periods in the presence of excess tertiary amine. The standard corrective measure is preactivation below −5°C, addition of the amino component within 2 min, and use of no more than 1.05 eq activating reagent relative to CBZ-D-tryptophan. Unlike Fmoc-D-tryptophan, which is selected for routine solid-phase peptide synthesis and is removed by 20% piperidine in DMF, CBZ-D-tryptophan cannot be removed under solid-phase-compatible basic conditions. Its final deprotection requires hydrogenolysis or HBr/AcOH, which may be incompatible with sequences containing thioethers, reduction-sensitive moieties, or some halogenated residues. In such cases, Boc-D-tryptophan is substituted if acid lability is acceptable. Published data for continuous-flow use of this exact D-tryptophan scaffold are limited, but stirred-batch observations on 1 L reactors with recirculating coolant show that temperature control is the primary variable governing epimerisation.

Protecting-Group Orthogonality and Side Reactions with the Indole N–H

The indole N–H of CBZ-D-tryptophan is generally not protected during standard peptide coupling at 0–5°C, because acylation of the indole nitrogen is slow under neutral or mildly basic conditions. However, strong bases such as sodium hydride in DMF or lithium diisopropylamide deprotonate the indole and introduce competing N-acylation and alkylation pathways. When the downstream sequence requires prolonged exposure to active esters or acid chlorides, indole protection with formyl or tert-butyloxycarbonyl may be considered, but the additional protection step changes the deprotection strategy and increases process cost. Side reactions involving indole oxidation are minimised by storing CBZ-D-tryptophan away from strong oxidising agents and by excluding dissolved oxygen from hydrogenation mixtures. In process comparison, the product occupies a distinct position relative to other D-tryptophan reagents: it is more acid-stable than Boc-D-tryptophan, more base-stable than Fmoc-D-tryptophan, and more lipophilic than unprotected D-tryptophan. This orthogonality window is useful when a peptide fragment must survive repeated acidic and basic workup cycles before final hydrogenolytic deprotection.

Fourier-transform infrared spectra of CBZ-D-tryptophan show the carbamate carbonyl stretching envelope between 1680 cm⁻¹ and 1740 cm⁻¹, the carboxylic acid carbonyl near 1700 cm⁻¹, and the indole N–H stretching band near 3400 cm⁻¹. Proton NMR in DMSO-d₆ resolves the benzyl methylene singlet at approximately δ 4.98–5.05, the aromatic envelope at δ 6.95–7.45, the indole N–H at approximately δ 10.80, and the carboxylic acid proton as a broad singlet at δ 12.4–12.7. Mass spectrometric confirmation gives the protonated molecular ion [M+H]⁺ at m/z 339.36 and the deprotonated ion [M−H]⁻ at m/z 337.36. These signals distinguish CBZ-D-tryptophan from Boc-D-tryptophan, which shows a characteristic tert-butyl singlet near δ 1.30–1.40 in ¹H NMR and a different mass offset from the protecting group. Under reversed-phase HPLC conditions of 0.1% trifluoroacetic acid in water/acetonitrile, the Cbz group increases retention relative to Boc-D-tryptophan, requiring gradient adjustment to avoid coelution with the corresponding L-enantiomer during method transfer.